Global Gene Expression Analysis of Early Response to Chemotherapy Treatment in Ovarian Cancer Spheroids

BMC Genomics - United Kingdom
doi 10.1186/1471-2164-9-99
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Heterotypic CAF-tumor Spheroids Promote Early Peritoneal Metastatis of Ovarian Cancer

Journal of Experimental Medicine
MedicineAllergyImmunology
2019English

Chemotherapy Weakly Contributes to Predicted Neoantigen Expression in Ovarian Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Germline BRCA, Chemotherapy Response Scores, and Survival in the Neoadjuvant Treatment of Ovarian Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Could HE4 Level Measurements During First-Line Chemotherapy Predict Response to Treatment Among Ovarian Cancer Patients?

PLoS ONE
Multidisciplinary
2018English

Integrated Analysis of Gene Expression and DNA Methylation Profiles in Ovarian Cancer

Journal of Ovarian Research
GynecologyOncologyObstetrics
2020English

Primary Chemotherapy Patterns for Ovarian Cancer Treatment in Japan

Journal of Obstetrics and Gynaecology Research
MedicineGynecologyObstetrics
2009English

Counterpoint: Intraperitoneal Chemotherapy: An Investigational Treatment in Ovarian Cancer

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2004English

Enhancing Chemotherapy Response With Bmi-1 Silencing in Ovarian Cancer

PLoS ONE
Multidisciplinary
2011English

Genetic Polymorphisms and Ovarian Cancer Risk and Response to Paclitaxel/Cisplatin Chemotherapy

Hereditary Cancer in Clinical Practice
OncologyGenetics
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy